BRCA1 H1862L

CI-VAR-00001909Explore in graph →NP_009225.1:p.His1862LeuNM_007294.4:c.5585A>TClinVar 55637 CIViC 3996 rs80357183

Curated evidence

Evidence by cancer (1 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–1 of 1 evidence items across 1 cancer context on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Unmapped disease1unmapped disease
BRCA1 H1862L	(functional)	Functional	D	Supports Unaltered Function	3	submitted	EID10319 High-throughput functional assays were used to classify BRCA1 missense mutations with unknown effects. A complementation assay was developed using BRCA1-null conditional knockout mouse embryonic stem … (full text at CIViC) PMID 23867111 · Bouwman et al., 2013 · Open in CIViC	civic

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
55637	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	2	Hereditary breast ovarian cancer syndrome; Breast-ovarian cancer, familial, susceptibility to, 1; Hereditary cancer-predisposing syndrome; Malignant tumor of breast; Familial cancer of breast	germline	9	Jan 26, 2026